Different nutritional-state indicators of HIV-positive individuals undergoing antiretroviral therapy

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 14, Issue 2, 2008, Pages 338-356

  Geraix, J ^a   Carvalhaes, M A B L ^a   Pereira, Paulo Câmara Marques ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antiretroviral therapy; HIV AIDS; Nutritional indicators

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 45349092554     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992008000200011     Document Type: Article

References (45)

1. BARBOSA RMR., FORNÉS NS. Avaliação nutricional em pacientes infectados pelo vírus da imunodeficiência adquirida. Rev. Nutr., 2003, 16, 461-70.
2. BATTERHAM MJ., GARSIA R., GREENOP P. Measurement of body composition in people with HIV/AIDS: a comparison of bioelectrical impedance and skinfold anthropometry with dual-energy x-ray absorptiometry. J. Am. Diet. Assoc., 1999, 99, 1109-11.
3. BODASING N., FOX R. HIV-associated lipodystrophy syndrome: description and pathogenesis. J. Infect., 2003, 46, 149-54.
4. BRITO AM., CASTILHO EA., SZWARCWALD CL. Aids e infecção pelo HIV no Brasil: uma epidemia multifacetada. Rev. Soc. Bras. Med. Trop., 2000, 34, 207-17.
5. CARR A., MILLER J., LAW M., COOPER DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS, 2000, 14, 25-32.
6. CARR A., SAMARAS K., BURTON S., LAW M., FREUND J., CHISHOLM DJ., COOPER DA. A syndrome of peripheral lipodistrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 1998a, 12, 51-8.
7. CARR A., SAMARAS K., CHISHOLM DJ., COOPER DA. Pathogenesis of HIV-1 - protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance. Lancet, 1998b, 351, 1881-3.
8. CARR A., SAMARAS K., THORISDOTTIR A. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet, 1999, 353, 2093-9.
9. CHLEBOWSKI RT., GROSVENOR MB., BARNHARD NH., MORALES LS., BULCAVAGE LM. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am. J. Gastroenterol., 1989, 84, 1288-93.
10. CHRISTEFF N., MELCHIOR JC., TRUCHIS P., PERRONE C., NUNEZ EA., GOUGEON ML. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS, 1999, 13, 2251-60.
11. CRONK CE., ROCHE AF. Race and sex-specific reference data for triceps and subscapular skinfolds and weight/stature. Am. J. Clin. Nutr., 1982, 35, 347-54.
12. DURNIN VGA., WOMERSLEY J. Body fat assessed from total body sensitivity and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. British J. Nutr., 1974, 32, 77-97.
13. FERRINI MT., PASTERNAK J., WAITZBERG DL. Síndrome da Imunodeficiência Adquirida (AIDS). In: WAITZBERG DL. Ed. Nutrição oral, enteral e parenteral na prática clínica. São Paulo: Atheneu, 2000: 1301-22.
14. FLETCHEN RH., FLETCHEN SW. Epidemiologia clínica. Porto Alegre: Armed, 2006.
15. FLORINDO AA., LATORRE MRDO., SANTOS ECM., BORELLI A., ROCHA MS., SEGURADO AAC. Validação de métodos de estimativa da gordura corporal em portadores do HIV/Aids. Rev. Saúde Públ., 2004, 38, 643-9.
16. FRISANCHO R. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and elderly. Am. J. Clin. Nutr., 1984, 40, 808-19.
17. GRINSPOON S., CORCORAN C., LEE K., BURROWS B., HUBBARD J., KATZNELSON L., WALSH M., GUCCIONE A., CANNAN J., HELLER H., BASGOZ N., KLIBANSKI A. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J. Clin. Endocrinol. Metab., 1996, 81, 4051-8.
18. GUERRA EML., GÓMEZ FB., HERNÁNDEZ LEP., CRESPO OT., ROMERO OB. Influencia de la infección por VHI/SIDA sobre algunos indicadores bioquímicos del estado nutricional. Rev. Cuba. Aliment. Nutr., 2002, 16, 119-26.
19. HARTMAN K., VERWEEL G., GROOT R., HARTWIG NG. Detection of lipoatrophy in human immunodeficiency virus-1-infeted children treated with highly active antiretroviral therapy. Pediatr. Infect. Dis. J., 2006, 25, 427-31.
20. HEYWARD VH., STOLARCZYR LM. Avaliação da composição corporal aplicada. São Paulo: Manole, 2000.
21. HODGSON LM., GHATTAS H., PRITCHITT H., SCHWENK A., PAYNE L., MACALLAN DC. Wasting and obesity in HIV outpatients. AIDS, 2001, 15, 2341-2. [Letter].
22. JAIME PC., FLORINDO AA., LATORRE MRDO., BRASIL BG., SANTOS ECM., SEGURADO AAC. Prevalência de sobrepeso e obesidade abdominal em indivíduos portadores de HIV/AIDS, em uso de terapia anti-retroviral de alta potência. Rev. Bras. Epidemiol., 2004, 7, 65-72.
23. JAIME PC., FLORINDO AA., LATORRE MRDO., SEGURADO AAC. Central obesity and dietary intake in HIV/AIDS patients. Rev. Saúde Públ., 2006, 40, 634-40.
24. KAPLAN LA. Laboratory utilization for nutrition support: current practice, requirements, and expectations. The cross conference. Clin. Chem., 1994, 40, 268-70.
25. KOTLER DP., TIERNEY AR., WANG J., PIERSON RN. Magnitude of body-cellmass depletion and timing of death from wasting in AIDS. Am. J. Clin. Nutr., 1989, 50, 444-7.
26. KOTLER DP., WANG J., PIERSON JR RN. Studies of body composition in patients with the acquired immunodeficiency syndrome. Am. J. Clin. Nutr., 1985, 42, 1255-65.
27. LEMONNIER D., ACHER S., BOUKAIBA N., FLAMENT C., DOUCET C., PIAU A., CHAPPUIS P. Discrepancy between anthropometric and biochemistry in the assessment of the nutritional status of the elderly. Eur. J. Clin. Nutr., 1991, 45, 281-6.
28. MARTINEZ E., MOCROFT A., GARCÍA-VIEJO MA., PÉREZ-CUEVAS JB., BLANCO JL., MALLOLAS J., BIANCHI L., CONGET I., BLANCH J., PHILLIPS A., GATELL JM. Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study. Lancet, 2001, 357, 592-8.
29. MATHIAS MRC., CERVI EC., MIRA LR., CURI PR., BURINI RC. Estabelecimento das faixas de normalidade de variáveis hematológicas e bioquímicas de indivíduos adultos. Influência do sexo e da faixa etária. Rev. Bras. Patol. Clin., 1986, 22, 106-12.
30. MCDERMOTT AY., SHEVITZ A., KNOX T., ROUBENOFF R., KEHAYIAS J., GORBACH S. Effect of high active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am. J. Clin. Nutr., 2001, 74, 679-86.
31. MUURAHAINEN N., SANTOS G., KLEINTOP M. Gender differences in HIV-associated adipose redistribution syndrome (HARS): an update. In: CONFERENCE ON RETROVIRUS AND OPPORTUNISTIC INFECTIONS, 7, San Francisco. Proceedings... San Francisco, 2000. [Abstract 26].
32. NIYONGABO T., BOUCHAUD O., HENZEL D., MELCHIOR JC., SAMB B., DAZZA MC., RUGGERI C., BEGUE JC., COULAUD JP., LAROUZÉ B. Nutritional status of HIV-seropositive subjects in an AIDS clinic in Paris. Eur. J. Clin. Nutr., 1997, 51, 637-40.
33. OTT M., FISHER H., POLAT H., HELM EB., FRENZ M., CASPARY WF., LEMBCKE B. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 1995, 9, 20-5.
34. OTT M., LEMBCKE B., FISCHER H., JÄGER R., POLAT R., GEIER H., RECH M., STASZESWKI S., HELM E., CASPRAY W. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am. J. Clin. Nutr., 1993, 57, 15-9.
35. PALENICEK J., GRAHAM N., HE Y., HOOVER DA., OISHI JS., KINGSLEY L., SAAH AJ. Weight loss prior to clinical AIDS as a predictor of survival. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 1995, 10, 366-73.
36. PAPINI-BERTO SJ., DICHI I., VICTÓRIA CR., BURINI RC. Protein-energy malnutrition as consequence of gastroenterologic patients hospitalization. Arq. Gastroenterol., 1997, 34, 13-21.
37. PATELLA JR FJ., DELANEY KM., MOORMAN AC., LOVELESS MO., FUHRER J., SATTEN GA., ASCHMAN DJ., HOLMBERG SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med., 1998, 338, 853-60.
38. POLACOW VO., SCAGLIUSI FB., FURTADO LSM., CARRÉ ML., PEREIRA GM., AVILEIS CG., GUIDIN D., SOUZA SB., MARUCCI MFN. Alterações do estado nutricional e dietoterapia na infecção por HIV. Rev. Bras. Nutr. Clin., 2004, 19, 78-85.
39. RODRIGUES JÚNIOR AL., CASTILHO EA. A epidemia de Aids no Brasil, 1991-2000: descrição espaço-temporal. Rev. Soc. Bras. Med. Trop., 2004, 37, 312-7.
40. SAINT-MARC T., PARTISANI M., POIZOT-MARTIN I., ROUVIERE O., BRUNO F., AVELLANEDA R., LANG JM., GASTAUT JA., TOURAINE JL. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS, 2000, 14, 37-49.
41. SUTTMANN U., OCKENGA J., SELBERG O., HOOGESTRAAT L., DEICHER H., MULLER MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 1995, 8, 239-46.
42. WAITZBERG DL., FERRINI MT. Exame físico e antropometria. In: WAITZBERG DL. Ed. Nutrição oral, enteral e parenteral na prática clínica. São Paulo: Atheneu, 2000: 255-78.
43. WANKE CA., SILVA M., KNOX TA., FORRESTER J., SPEIGELMAN D., GORBACH SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin. Infect. Dis., 2000, 31, 803-5.
44. WORLD HEALTH ORGANIZATION. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization, 2000. [WHO Technical Report Series, 894].
45. WORLD HEALTH ORGANIZATION. Report of a WHO Expert Committee. Physical status: the use and interpretation of anthropometry. Geneva: World Health Organization, 1998. [WHO Technical Report Series, 854].